- Report
- January 2024
- 200 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- November 2023
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1442EUR$1,500USD£1,236GBP
- Report
- November 2023
- 92 Pages
Global
From €7209EUR$7,500USD£6,182GBP
- Report
- June 2023
- 338 Pages
Global
From €7209EUR$7,500USD£6,182GBP
- Report
- March 2024
- 200 Pages
Global
From €3989EUR$4,150USD£3,421GBP
- Report
- January 2024
- 200 Pages
Global
From €3989EUR$4,150USD£3,421GBP
- Report
- April 2023
- 125 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- April 2023
- 180 Pages
Global
From €3124EUR$3,250USD£2,679GBP
- Report
- July 2022
- 60 Pages
China
From €2835EUR$2,950USD£2,431GBP
- Report
- July 2022
- 30 Pages
Global
From €1153EUR$1,200USD£989GBP
- Report
- May 2021
- 250 Pages
Global
From €8602EUR$8,950USD£7,377GBP
- Report
- August 2022
- 115 Pages
Global
From €4325EUR$4,500USD£3,709GBP
- Report
- April 2022
- 112 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Drug Pipelines
- August 2018
- 79 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Report
- January 2021
- 149 Pages
China, Global
From €3000EUR$3,344USD£2,663GBP
- Report
- May 2024
- 50 Pages
Global
From €2547EUR$2,650USD£2,184GBP
Brimonidine is a medication used in animal pharmaceuticals to treat glaucoma, a condition that causes increased pressure in the eye. It is a type of alpha-2 agonist, which works by decreasing the amount of fluid produced in the eye. Brimonidine is available in both topical and oral forms, and is commonly used in veterinary medicine to treat glaucoma in cats and dogs. It is also used to treat other ocular conditions, such as uveitis and dry eye.
Brimonidine is generally well-tolerated and has few side effects. It is important to follow the instructions of a veterinarian when administering the medication, as it can cause drowsiness and other adverse reactions.
The brimonidine market is an important part of the animal pharmaceuticals industry. It is used to treat a variety of ocular conditions in cats and dogs, and is generally well-tolerated.
Some companies in the brimonidine market include Zoetis, Merck Animal Health, Elanco Animal Health, and Bayer Animal Health. Show Less Read more